General
India expects lion’s share of surplus US AstraZeneca vaccines as COVID-19 cases mount
India expects to secure the biggest chunk of the 60 million AstraZeneca COVID-19 vaccine doses that the United States will share globally, two Indian government sources said as New Delhi battles a devastating surge in infections.
Key points:
-
Indian government sources say they expect India to receive the largest chunk of the US’s surplus vaccine doses
-
COVID-19 cases in India continue to rise, with the eastern state of West Bengal primed to be the country’s next big outbreak
-
India’s High Commission in Canberra responded to a news article in The Australian criticising Prime Minister Narendra Modi, calling it “malicious” and “slanderous”
On Monday, the White House said 10 million doses could be cleared for export “in coming weeks” and the rest…
Continue Reading